INMB icon

INmune Bio

72 hedge funds and large institutions have $29.5M invested in INmune Bio in 2024 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 35 increasing their positions, 6 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
72
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.78M
Puts
$379K
Net Calls
Net Calls Change

Top Buyers

1 +$435K
2 +$415K
3 +$389K
4
Renaissance Technologies
Renaissance Technologies
New York
+$367K
5
Morgan Stanley
Morgan Stanley
New York
+$294K

Top Sellers

1 -$410K
2 -$329K
3 -$280K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$193K
5
Squarepoint
Squarepoint
New York
-$182K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$4.62M
2
$3.79M
3
$3.45M
4
$2.22M
5
$1.7M
6
$1.36M
7
$1.06M
8
$896K
9
$868K
10
$833K
11
$724K
12
$724K
13
$636K
14
$513K
15
$495K
16
$471K
17
$420K
18
$389K
19
$362K
20
$310K
21
$297K
22
$286K
23
$244K
24
$235K
25
$219K